Inotek Jumps After Detailing Rocket's Near-Term Clinical Catalysts
October 13, 2017 at 16:12 PM EDT
Inotek Pharmaceuticals last night announced the filing with the SEC of the company's preliminary proxy statement in connection with the previously announced proposed combination with Rocket Pharmaceuticals.
